Which has the lower trailing P/E, ELV or NVS?

ELV has the lower trailing P/E: ELV trades at 17.17 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ELV or NVS?

Over the past five years, ELV grew revenue faster — ELV at a 9.25% CAGR versus NVS at 1.53%.

Does ELV or NVS pay a bigger dividend?

ELV yields 1.80% and NVS yields 3.38% based on trailing dividends and the latest price.

Is ELV or NVS more profitable?

NVS runs the higher net margin — ELV at 2.47% versus NVS at 22.93%.

How have ELV and NVS total returns compared?

Over the past 10 years, ELV delivered 13.33% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Elevance Health Inc. (ELV) vs Novartis AG (NVS)

A side-by-side comparison of Elevance Health Inc. and Novartis AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

ELV

Elevance Health Inc.

$83.80B

$386.43HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

NVS

Novartis AG

$268.00B

$141.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — ELV vs NVS

growth of $100 · dividends reinvested · last 10y

ELV +258.8% (+13.6%/yr)NVS +209.2% (+12.0%/yr)ELV compounded faster over this window

ELV NVS

ELV vs NVS: by the numbers

•NVS is the larger company ($268.00B vs $83.80B market cap).
•ELV trades at the lower trailing earnings multiple (17.17 vs 21.27 P/E), one valuation lens rather than an overall verdict.
•NVS converts more revenue to profit (22.93% vs 2.47% net margin).
•ELV grew revenue faster over the past five years (9.25% vs 1.53% CAGR).
•NVS pays the higher dividend yield (3.38% vs 1.80%).

Metrics side by side

Valuation

Metric	ELV	NVS
P/E ratio	17.17	21.27
Forward P/E	14.22	16.02
PEG ratio	2.48	1.38
P/S ratio	0.42	4.82
P/B ratio	1.87	6.45
EV / EBITDA	12.95	13.85
FCF yield	7.50%	5.90%

Profitability

Metric	ELV	NVS
Gross margin	25.56%	74.44%
Operating margin	3.51%	30.54%
Net margin	2.47%	22.93%
ROE	11.06%	30.71%
ROIC	6.34%	13.93%

Dividends

Metric	ELV	NVS
Dividend yield	1.80%	3.38%
Payout ratio	30.53%	71.50%

Growth (annualized)

Metric	ELV	NVS
Revenue CAGR (5Y)	9.25%	1.53%
EPS CAGR (5Y)	6.67%	15.42%
FCF CAGR (5Y)	-19.97%	8.92%
Total return CAGR (5Y)	1.78%	16.96%

Frequently asked

Which has the lower trailing P/E, ELV or NVS?: ELV has the lower trailing P/E: ELV trades at 17.17 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ELV or NVS?: Over the past five years, ELV grew revenue faster — ELV at a 9.25% CAGR versus NVS at 1.53%.
Does ELV or NVS pay a bigger dividend?: ELV yields 1.80% and NVS yields 3.38% based on trailing dividends and the latest price.
Is ELV or NVS more profitable?: NVS runs the higher net margin — ELV at 2.47% versus NVS at 22.93%.
How have ELV and NVS total returns compared?: Over the past 10 years, ELV delivered 13.33% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ELV analysis Full NVS analysis Interactive comparison tool

Dig into the metrics

Elevance Health P/E ratio Novartis AG P/E ratio Elevance Health dividend yield Novartis AG dividend yield Elevance Health ROE Novartis AG ROE Elevance Health operating margin Novartis AG operating margin Elevance Health revenue growth Novartis AG revenue growth Elevance Health free cash flow Novartis AG free cash flow

Elevance Health & Novartis AG appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.